Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Radiotherapy in Elderly Patients with Cancer

고령 암 환자의 방사선치료

  • Chun, Mi-Son (Department of Radiation Oncology, Ajou University School of Medicine) ;
  • Jo, Sun-Mi (Department of Radiation Oncology, Ajou University School of Medicine)
  • 전미선 (아주대학교 의과대학 방사선종양학교실) ;
  • 조선미 (아주대학교 의과대학 방사선종양학교실)
  • Received : 2010.11.04
  • Accepted : 2011.02.10
  • Published : 2011.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Due to improved life spans, cancer incidence has increased with more aged patients presenting with cancer. Elderly cancer patients could have compromised organ function and/or comorbidities. Due to poor social support or lack of early diagnosis, treatment outcomes for elderly cancer patients are poor in general. However, with aggressive support during cancer management as well as careful selection, most elderly cancer patients can tolerate standard radiation therapy with good results based on published articles. Here, we reviewed existing articles regarding compliance and treatment results in elderly cancer patients based on tumor site.

평균수명이 길어짐에 따라 암 발생률이 증가하고 있고, 보다 고령의 환자가 많아졌다. 자연적으로 고령의 암 환자는 장기 기능이 퇴화되고 동반질환을 갖는 경우가 흔하다. 사회적인 지지부족이나 조기진단의 부족으로 고령 암 환자의 치료는 일반적으로 빈약하다. 그러나 발표된 논문들을 바탕으로 하였을 때 신중히 환자 선택을 하여 암 치료 기간 동안 적극적인 지지치료를 한다면 대부분의 고령환자는 표준 치료를 잘 견디면서 좋은 결과를 얻을 수 있었다. 이에 저자들은 각각의 암에 대한 고령 환자의 치료 순응도와 치료 결과에 대한 논문들을 리뷰해 보았다.

Keywords

References

  1. National Cancer Information Center. Cancer statistics [Internet]. Goyang: National Cancer Information Center; [cited 2011 Jan 20]. Available from: http://www.cancer.go.kr/cms/statistics/survival_rate
  2. Pignon T, Gregor A, Schaake Koning C, Roussel A, Van Glabbeke M, Scalliet P. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998;46:239-248 https://doi.org/10.1016/S0167-8140(97)00188-6
  3. Horiot JC. Radiation therapy and the geriatric oncology patient. J Clin Oncol 2007;25:1930-1935 https://doi.org/10.1200/JCO.2006.10.5312
  4. Bellizzi KM, Mustian KM, Palesh OG, Diefenbach M. Cancer survivorship and aging: moving the science forward. Cancer 2008;113(12 Suppl):3530-3539 https://doi.org/10.1002/cncr.23942
  5. Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. West J Med 1981;135:434-440
  6. Brandtstadter J, Renner G. Tenacious goal pursuit and flexible goal adjustment: explication and age-related analysis of assimilative and accommodative strategies of coping. Psychol Aging 1990;5:58-67 https://doi.org/10.1037/0882-7974.5.1.58
  7. Blank TO, Bellizzi KM. A gerontologic perspective on cancer and aging. Cancer 2008;112(11 Suppl):2569-2576 https://doi.org/10.1002/cncr.23444
  8. Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 2004;40:673-680 https://doi.org/10.1016/j.ejca.2003.12.007
  9. Paulino AC, Constine LS, Rubin P, Williams JP. Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol 2010;20:12-20 https://doi.org/10.1016/j.semradonc.2009.08.003
  10. Gouin JP, Hantsoo L, Kiecolt-Glaser JK. Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation 2008;15:251-259 https://doi.org/10.1159/000156468
  11. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639-646 https://doi.org/10.1111/j.1532-5415.1999.tb01583.x
  12. Ogata K, Yokose N, Tamura H, et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997;84:269-275 https://doi.org/10.1006/clin.1997.4401
  13. Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 1999;17:82-94 https://doi.org/10.1016/S0264-410X(98)00117-0
  14. Gravenstein S, Drinka P, Duthie EH, et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc 1994;42:245-251 https://doi.org/10.1111/j.1532-5415.1994.tb01746.x
  15. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-270 https://doi.org/10.1146/annurev.med.51.1.245
  16. Gosain A, DiPietro LA. Aging and wound healing. World J Surg 2004;28:321-326 https://doi.org/10.1007/s00268-003-7397-6
  17. Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 1998;78:47-58
  18. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997;80:1273-1283 https://doi.org/10.1002/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4
  19. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242 https://doi.org/10.1056/NEJMoa011795
  20. Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293:1073-1081 https://doi.org/10.1001/jama.293.9.1073
  21. Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst 1996;88:1031-1038 https://doi.org/10.1093/jnci/88.15.1031
  22. Bouvier AM, Launoy G, Lepage C, Faivre J. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther 2005;22:233-241 https://doi.org/10.1111/j.1365-2036.2005.02559.x
  23. Vercelli M, Capocaccia R, Quaglia A, Casella C, Puppo A, Coebergh JW. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol 2000;35:161-179 https://doi.org/10.1016/S1040-8428(00)00075-5
  24. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20:494-502 https://doi.org/10.1200/JCO.20.2.494
  25. Gomez H, Hidalgo M, Casanova L, et al. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol 1998;16:2065-2069 https://doi.org/10.1200/JCO.1998.16.6.2065
  26. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood 2006;107:3481-3485 https://doi.org/10.1182/blood-2005-09-3724
  27. Wedding U, Rohrig B, Klippstein A, Fricke HJ, Sayer HG, Hoffken K. Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol 2006;132:665-671 https://doi.org/10.1007/s00432-006-0115-7
  28. Klepin HD, Geiger AM, Tooze JA, et al. Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study. J Am Geriatr Soc 2010;58:76-82 https://doi.org/10.1111/j.1532-5415.2009.02620.x
  29. Lin LL, Hahn SM. Combined modality therapy in the elderly population. Curr Treat Options Oncol 2009;10:195-204 https://doi.org/10.1007/s11864-009-0105-5
  30. Albrand G, Terret C. Early breast cancer in the elderly: assessment and management considerations. Drugs Aging 2008;25:35-45 https://doi.org/10.2165/00002512-200825010-00004
  31. Silliman RA. When cancer in older adults is undermanaged: the breast cancer story. J Am Geriatr Soc 2009;57(Suppl 2):S259-S261 https://doi.org/10.1111/j.1532-5415.2009.02506.x
  32. Alberg AJ, Singh S. Epidemiology of breast cancer in older women: implications for future healthcare. Drugs Aging 2001;18:761-772 https://doi.org/10.2165/00002512-200118100-00005
  33. Bouchardy C, Rapiti E, Fioretta G, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003;21:3580-3587 https://doi.org/10.1200/JCO.2003.02.046
  34. Sanghani M, Balk EM, Cady B. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer 2009;115:1613-1620 https://doi.org/10.1002/cncr.24174
  35. Martelli G, Miceli R, De Palo G, et al. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla? Cancer 2003;97:1156-1163 https://doi.org/10.1002/cncr.11173
  36. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003 https://doi.org/10.1023/A:1011136326943
  37. Livi L, Paiar F, Meldolesi E, et al. The management of elderly patients with T1-T2 breast cancer treated with or without radiotherapy. Eur J Surg Oncol 2005;31:473-478 https://doi.org/10.1016/j.ejso.2005.02.024
  38. Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006;98:681-690 https://doi.org/10.1093/jnci/djj186
  39. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-977 https://doi.org/10.1056/NEJMoa040587
  40. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009;74:987-1001 https://doi.org/10.1016/j.ijrobp.2009.02.031
  41. Smith BD, Haffty BG, Hurria A, Galusha DH, Gross CP. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 2006;24:4901-4907 https://doi.org/10.1200/JCO.2006.06.5938
  42. Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol 2010;28:380-386 https://doi.org/10.1200/JCO.2009.23.5440
  43. Yu HM, Liu YF, Yu JM, Liu J, Zhao Y, Hou M. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer. Radiother Oncol 2008;87:29-34 https://doi.org/10.1016/j.radonc.2008.01.008
  44. Werner-Wasik M, Scott C, Cox JD, et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 2000;48:1475-1482 https://doi.org/10.1016/S0360-3016(00)00801-4
  45. Jatoi A, Hillman S, Stella P, et al. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005;23:9113-9119 https://doi.org/10.1200/JCO.2005.03.7465
  46. Schild SE, Stella PJ, Geyer SM, et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003;21:3201-3206 https://doi.org/10.1200/JCO.2003.12.019
  47. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909 https://doi.org/10.1136/bmj.311.7010.899
  48. Movsas B, Scott C, Sause W, et al. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 1999;45:1143-1149 https://doi.org/10.1016/S0360-3016(99)00325-9
  49. Langer CJ, Hsu C, Curran WJ, et al. Elderly patients (pts) with locally advanced non-small cell lung cancer (LA-NSCLC) benefit from conbined modality therpy: secondary analysis of Radiation Therapy Oncology Group (RTOG) 94-10. Proc Am Soc Clin Oncol 2002;21:abstr1193
  50. Redmond KJ, Song DY. Thoracic irradiation in the elderly. Thorac Surg Clin 2009;19:391-400 https://doi.org/10.1016/j.thorsurg.2009.06.003
  51. Scott CB, Scarantino C, Urtasun R, et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998;40:51-55 https://doi.org/10.1016/S0360-3016(97)00485-9
  52. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-710 https://doi.org/10.1093/jnci/85.9.704
  53. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 1998;42:981-987 https://doi.org/10.1016/S0360-3016(98)00296-X
  54. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007;356:1527-1535 https://doi.org/10.1056/NEJMoa065901
  55. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 2004;22:1583-1588 https://doi.org/10.1200/JCO.2004.06.082
  56. Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994;29:835-839 https://doi.org/10.1016/0360-3016(94)90573-8
  57. Thomas R, James N, Guerrero D, Ashley S, Gregor A, Brada M. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 1994;33:113-116 https://doi.org/10.1016/0167-8140(94)90064-7
  58. Ford JM, Stenning SP, Boote DJ, et al. A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin Oncol (R Coll Radiol) 1997;9:20-24 https://doi.org/10.1016/S0936-6555(97)80053-2
  59. Lutterbach J, Ostertag C. What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma? J Clin Oncol 2005;23:2869-2870 https://doi.org/10.1200/JCO.2005.05.238
  60. Roa W, Xing JZ, Small C, et al. Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme. Expert Rev Anticancer Ther 2009;9:1643-1650 https://doi.org/10.1586/era.09.128
  61. Sijben AE, McIntyre JB, Roldan GB, et al. Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 2008;89:97-103 https://doi.org/10.1007/s11060-008-9593-6
  62. Combs SE, Wagner J, Bischof M, et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 2008;70:987-992 https://doi.org/10.1016/j.ijrobp.2007.07.2368
  63. Minniti G, De Sanctis V, Muni R, et al. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J Neurooncol 2009;91:95-100 https://doi.org/10.1007/s11060-008-9689-z
  64. Syrigos KN, Karachalios D, Karapanagiotou EM, Nutting CM, Manolopoulos L, Harrington KJ. Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer Treat Rev 2009;35:237-245 https://doi.org/10.1016/j.ctrv.2008.11.002
  65. Pignon T, Horiot JC, Van den Bogaert W, Van Glabbeke M, Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 1996;32A:2075-2081
  66. Huguenin P, Sauer M, Glanzmann C, Lutolf UM. Radiotherapy for carcinomas of the head and neck in elderly patients. Strahlenther Onkol 1996;172:485-488
  67. Schofield CP, Sykes AJ, Slevin NJ, Rashid NZ. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 2003;69:37-42 https://doi.org/10.1016/S0167-8140(03)00249-4
  68. Oguchi M, Ikeda H, Watanabe T, et al. Experiences of 23 patients ＞or =90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998;41:407-413 https://doi.org/10.1016/S0360-3016(98)00052-2
  69. Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ, Marijnen CA. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 2008;9:494-501 https://doi.org/10.1016/S1470-2045(08)70129-3
  70. Dobie SA, Warren JL, Matthews B, Schwartz D, Baldwin LM, Billingsley K. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer 2008;112:789-799 https://doi.org/10.1002/cncr.23244
  71. Pignon T, Horiot JC, Bolla M, et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol 1997;42:107-120 https://doi.org/10.1016/S0167-8140(96)01861-0
  72. Kunos C, Tian C, Waggoner S, Rose PG, Lanciano R. Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study. Int J Gynecol Cancer 2009;19:1258-1263 https://doi.org/10.1111/IGC.0b013e3181b33ace
  73. Alektiar KM, Venkatraman E, Abu-Rustum N, Barakat RR. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 2003;98:2368-2377 https://doi.org/10.1002/cncr.11830
  74. Huscher A, Bignardi M, Magri E, et al. Determinants of small bowel toxicity in postoperative pelvic irradiation for gynaecological malignancies. Anticancer Res 2009;29:4821-4826
  75. Yeh SA, Wan Leung S, Wang CJ, Chen HC. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Gynecol Oncol 1999;72:10-15 https://doi.org/10.1006/gyno.1998.5217
  76. Chen SW, Liang JA, Yang SN, et al. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Gynecol Oncol 2004;95:208-214 https://doi.org/10.1016/j.ygyno.2004.07.003
  77. Sandhu A, Mundt AJ. Radiation therapy for urologic malignancies in the elderly. Urol Oncol 2009;27:643-652 https://doi.org/10.1016/j.urolonc.2009.07.019
  78. Wong YN, Mitra N, Hudes G, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006;296:2683-2693 https://doi.org/10.1001/jama.296.22.2683
  79. Geinitz H, Zimmermann FB, Thamm R, Schumertl A, Busch R, Molls M. 3D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol 2005;76:27-34 https://doi.org/10.1016/j.radonc.2005.06.001
  80. Jani AB, Parikh SD, Vijayakumar S, Gratzle J. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Urology 2005;65:1157-1162 https://doi.org/10.1016/j.urology.2004.12.041
  81. Droz JP, Balducci L, Bolla M, et al. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. Crit Rev Oncol Hematol 2010;73:68-91 https://doi.org/10.1016/j.critrevonc.2009.09.005
  82. Nguyen PL, Chen MH, Renshaw AA, Loffredo M, Kantoff PW, D'Amico AV. Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations. Int J Radiat Oncol Biol Phys 2010;76:337-341 https://doi.org/10.1016/j.ijrobp.2009.01.045
  83. Hayes JH, Chen MH, Moran BJ, et al. Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke. BJU Int 2010;106:979-985 https://doi.org/10.1111/j.1464-410X.2010.09273.x
  84. Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 2007;99:1516-1524 https://doi.org/10.1093/jnci/djm168
  85. Balducci L, Yates J. General guidelines for the management of older patients with cancer. Oncology (Williston Park) 2000;14:221-227